Breast cancer Follow-Up overhaul: fewer hospital visits may be just as safe
NCT ID NCT07616258
First seen Jun 05, 2026 · Last updated Jun 21, 2026 · Updated 4 times
Summary
This study looks at whether women who finished treatment for early-stage breast cancer can safely reduce their hospital follow-up visits from five years to just two years, while still getting yearly mammograms. About 560 women will take part, with half following the usual schedule and half stopping clinic visits after two years. The goal is to see if fewer appointments can reduce stress and improve quality of life without missing any cancer recurrences.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EARLY-STAGE BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beaumont RCSI Cancer Centre
RECRUITINGBeaumont, Dublin, D09V2N0, Ireland
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to a simpler, less stressful follow-up schedule for breast cancer survivors, with fewer hospital visits and more care from their family doctor.
What could go wrong
This is an early-stage study with 560 participants, so results may not apply to everyone. There is a small risk that reducing visits could delay detection of a recurrence, though annual mammograms continue.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.